Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether inhaled Budesonide/formoterol is effective
in the treatment of bronchiolitis obliterans after allogeneic stem cell transplantation.
Phase:
Phase 2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate